Abstract Library

#4626 Comparison of two prognostic models for the treatment of pancreatic NET with PRRT

Introduction: The efficacy and time to progression (TTP) following peptide receptor radionuclide therapy (PRRT) for pancreatic neuroendocrine tumours varies widely.

Conference:

Presenting Author: Papantoniou D

Authors: Tiensuu Janson E, Fröss-Baron K, Grönberg M, Ziolkowska B,

Keywords: prrt, pancreatic neuroendocrine tumour, predictive model,

#4133 Clinical impact and prognosis of patients with Si-NET and bone metastases – Do they matter?

Introduction: The prevalence of bone metastases (BM) in small intestinal neuroendocrine tumors (Si-NET) ranges from 5 to 23 %.

Conference:

Presenting Author: Wedin M

Authors: Wedin M, Daskalakis K, Tiensuu Janson E, Sundin A, Wallin G,

Keywords: bone metastases, si-net, Neuroendocrine Neoplasm,

#3731 Rare metastases diagnosed on 68Ga-DOTATOC-PET/CT in small intestinal and pancreatic NETs

Introduction: Neuroendocrine metastases to the orbita, heart, breast, bone, Virchow's lymph node, and pancreas are rarely encountered in small intestinal (SI-NETs) and pancreatic NETs (P-NETs).

Conference:

Presenting Author: Wedin M

Authors: Wedin M, Daskalakis K, Wallin G, Sundin A, Tiensuu Janson E,

Keywords: Neuroendocrine Neoplasm, Rare metastases, Bone metastases, breast metastases, orbita metastases, heart metastases, Lung and pleural metastases, Pancreatic metastases,

#262 Changes on Chromosome 18 are Involved in Sporadic and Familial Ileal Carcinoid Tumor Development

Introduction: Small intestine neuroendocrine tumors (ileal carcinoid) is generally considered a sporadic disease. We have identified nine families with an ileal carcinoid tumor diagnosed in two or more individuals.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Tiensuu Janson E, Cunningham J, Diaz de Ståhl T, Sjöblom T, Westin G,

Keywords: genetics, ileal carcinoid, familial, pedigrees,

#112 Chromogranin A is a sensitive marker for detection of recurrence in neuroendocrine tumors

Introduction: The chromogranin family is a family of large acidic proteins which are expressed in neuroendocrine cells. There are several members in this family (Chromogranin A, B (CgA and CgB) and the secretogranins). Here, we show that CgA is an excellent marker to detect recurrence in neuroendocrine tumors.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Tiensuu Janson E, Welin S, Eriksson B, Stridsberg M,

Keywords: small intestinal carcinoid, chromogranin A, follow-up,